StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was $31.33M, down 36.7% from the year before. The highest annual figure on record is $49.49M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$31.33M-36.7%
FY2024Dec 31, 2024$49.49M–
FY2023Dec 31, 2023-$36.06M–
FY2022Dec 31, 2022-$34.59M–
FY2021Dec 31, 2021-$22.98M–
FY2020Dec 31, 2020-$28.49M–
FY2019Dec 31, 2019-$28.04M–
FY2018Dec 31, 2018-$13.45M–
FY2017Dec 31, 2017-$31.04M–
FY2016Dec 31, 2016-$22.42M–
FY2015Dec 31, 2015-$28.73M–
FY2014Dec 31, 2014-$13.04M–
FY2013Dec 31, 2013-$6.77M–
FY2012Dec 31, 2012-$11.85M–
FY2011Dec 31, 2011-$9.35M–
FY2010Dec 31, 2010-$4.33M–
FY2009Dec 31, 2009-$7.50M–

More Compugen figures

See a number that looks wrong?